PHOENIX Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) and COPEGUS (Ribavirin) Administered After Liver Transplantation for Hepatitis C.
Clinical trial NCT00087633 · COMPLETED
Trial details
- NCT number
- NCT00087633
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2004-10-01
- Primary completion
- 2008-10-01
- Enrollment
- 115
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.